Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiphospholipid syndrome.

E Gromnica-Ihle1, W Schössler

  • 1Medical Center for Rheumatology, Berlin, Germany. gromnica-ihle@berlin.snafu.de

International Archives of Allergy and Immunology
|October 3, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The S2k guideline: Indications for knee endoprosthesis : Evidence and consent-based indications for total knee arthroplasty].

Der Orthopade·2018
Same author

[S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs].

Zeitschrift fur Rheumatologie·2018
Same author

[Memorandum of the German Society for Rheumatology on the quality of treatment in rheumatology - Update 2016].

Zeitschrift fur Rheumatologie·2017
Same author

[Treat-to-target (T2T) recommendation for patients with spondyloarthritis - translation into German].

Zeitschrift fur Rheumatologie·2016
Same author

[Glucocorticoids].

Zeitschrift fur Rheumatologie·2016
Same author

[Standards of care for people with rheumatoid arthritis in Europe : Translation and comments of the eumusc.net recommendations supported by EULAR performed by a national task force of the professional organisations DGRh and VRA supported by "Deutsche Rheumaliga"].

Zeitschrift fur Rheumatologie·2016
Same journal

Differences in Reported Anaphylaxis Associated With Common Nonsteroidal Anti-inflammatory Drugs: A Pharmacovigilance Study.

International archives of allergy and immunology·2026
Same journal

Association of Serum Galectin-3 Binding Protein with Acute Exacerbation, Inflammation, and Airway Remodeling in Pediatric Asthma.

International archives of allergy and immunology·2026
Same journal

Effectiveness of a Provincial Law to Improve Epinephrine Use for Anaphylaxis in Schools in Alberta, Canada: A Pre-Post Study.

International archives of allergy and immunology·2026
Same journal

Rab27 a regulates dendritic cell immune tolerogenic capacity.

International archives of allergy and immunology·2026
Same journal

Burden of Hereditary Angioedema in Adults: Impact of Disease and Patient Characteristics.

International archives of allergy and immunology·2026
Same journal

Predictors of Treatment Response to Omalizumab in Children with Chronic Spontaneous Urticaria: A Real World Study.

International archives of allergy and immunology·2026
See all related articles

Antiphospholipid syndrome (APS) is an autoimmune disorder causing blood clots and pregnancy loss, diagnosed by antiphospholipid antibodies (aPL). It can be primary or secondary to other conditions like lupus erythematosus (SLE).

Area of Science:

  • Autoimmune diseases
  • Hematology
  • Reproductive immunology

Background:

  • Antiphospholipid syndrome (APS) is a significant autoimmune disorder.
  • It is characterized by recurrent thrombotic events (venous and arterial) and/or pregnancy morbidity.
  • The presence of antiphospholipid antibodies (aPL) is a key diagnostic feature.

Purpose of the Study:

  • To define the key characteristics of Antiphospholipid Syndrome (APS).
  • To outline diagnostic criteria for APS.
  • To differentiate between primary and secondary APS.

Main Methods:

  • Review of clinical and laboratory diagnostic criteria for APS.
  • Analysis of associations between APS and other autoimmune diseases, particularly SLE.
  • Discussion of the systemic impact of APS.

Related Experiment Videos

Main Results:

  • APS diagnosis requires clinical criteria (thrombosis or pregnancy morbidity) and laboratory confirmation of aPL.
  • APS can occur independently (primary) or in conjunction with other autoimmune conditions (secondary), notably systemic lupus erythematosus (SLE).
  • The condition affects nearly all organ systems.

Conclusions:

  • Accurate diagnosis of APS relies on both clinical presentation and specific immunological tests, including lupus anticoagulant and aPL determinations.
  • Understanding the distinction between primary and secondary APS is crucial for patient management.
  • APS is a multisystem disorder with significant clinical implications.